Early stage breast cancer: How to know whether to forgo chemo
- Written by Valerie Malyvanh Jansen, Clinical Instructor, Vanderbilt University
Woman receiving chemotherapy.From www.shutterstock.comThere has been substantial publicity about the MINDACT trial, which could lead to changes in breast cancer treatment. The study’s results suggest that women with a certain genetic profile would have a good chance of survival and cure regardless of chemotherapy.
While the results are...
Read more: Early stage breast cancer: How to know whether to forgo chemo






